EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹15 Cr | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹11 Cr |
How is Total Non-Current Liabilities of EVEREST ORGANICS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -29.69 | |
| Mar2024 | ₹21 Cr | 15.12 | |
| Mar2023 | ₹18 Cr | -3.16 | |
| Mar2022 | ₹19 Cr | 62.92 | |
| Mar2021 | ₹11 Cr | - | |
Compare Total Non-Current Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹280.6 Cr | -5.8% | -6.5% | -28.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.8% |
-6.5% |
-28.9% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses